Please help us continue to improve nanoHUB operation and service by completing our survey - http://bit.ly/nH-survey14. Thank you - we appreciate your time. close

Support

Support Options

Submit a Support Ticket

 

BME 695N Lecture 19: In vivo model systems to study nanomedical approaches to cancer detection and intervention

By Deborah W Knapp

Purdue University

Published on

Abstract

Outline:
  1. Role of animal models in translational cancer research
    1. Steps from the “bench” to the “bedside”
    2. The in vivo environment (3D, blood supply, microenvironment, immune system)
    3. Types of studies performed in animal models: biodistribution, pharmacokinetics, toxicity, “efficacy”
    4. Expertise of the team needed to take new approaches from the “bench” to the “bedside”
  2. Types of animal models available for translational cancer research
    1. Chemical induced by chemicals, irritants, light/radiation
    2. Syngeneic models
    3. Immunocompromised animals and “foreign” xenografts
    4. Transgenic animals
    5. Naturally-occurring animal models of cancer
  3. Naturally-occurring cancer in dogs as models for human cancer
    1. Models identified to date
    2. Naturally-occurring urinary bladder cancer in dogs
    3. Examples of ongoing studies in pet dogs
  4. Nanomedicine approaches studied in animals in the Knapp / Leary / Bergstrom labs and the Knapp / Frangioni labs
    1. Targeting programmable multilayer nanoparticles in breast cancer
    2. Sentinel lymph node mapping in urinary bladder cancer
    3. Future applications of nanomedicine approaches in urinary bladder cancer

References

  • Knapp DW, Glickman NW, DeNicola DB, Bonney PL, Lin TL, Glickman LT. Naturally-occurring canine transitional cell carcinoma of the urinary bladder: A relevant model of human invasive bladder cancer. Urol Oncol, 5:47-59, 2000.
  • Knapp DW, Adams LG, DeGrand AM, Niles JD, Weil AB, O’Donnell MA, Lucroy MD, and Frangioni JV. Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Euro Urology, in press, 2007.

Cite this work

Researchers should cite this work as follows:

  • Deborah W Knapp (2007), "BME 695N Lecture 19: In vivo model systems to study nanomedical approaches to cancer detection and intervention," http://nanohub.org/resources/3521.

    BibTex | EndNote

Time

Location

Biomedical Engineering Building, Room 1083

Tags

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.